最先进的技术审查:传染性腹
Andi L Shane1, Mark D Gonzalez2, Amanda M Roy3
1Division of Pediatric Infectious Disease, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
本综述概述了针对传染性腹管理的多学科方法,更新了指导方针,并讨论了诊断,表现和新兴的治疗方法,如生物疗法,以减少疾病负担.
科学领域:
- 传染性疾病 传染性疾病
- 胃肠病学 胃肠病学
- 微生物学 微生物学
- 临床药房 临床药房
背景情况:
- 传染性腹仍然是一个重要的健康问题,随着流行病学和病因学的发展.
- 美国传染病学会2017年指导方针为管理提供了基础.
- 了解传染性腹对个人和社区的影响至关重要.
研究的目的:
- 提出一个多学科的方法来管理传染性腹.
- 突出传染性腹流行病学,病因和表现方面的最新情况.
- 讨论诊断和新兴治疗策略的进展.
主要方法:
- 关于传染性腹的当前文献和指导方针的审查.
- 从传染病,胃肠病学,微生物学和药学角度整合观点.
- 对诊断方式的分析,包括基于分子和培养的测试.
- 评估新出现的抗菌素耐药性和生物治疗方案.
主要成果:
- 传染性腹具有各种急性,慢性和后传染性表现.
- 分子诊断 (文化独立的诊断测试) 和传统培养方法在诊断和监测中起着至关重要的作用.
- 抗菌素耐药性是传染性腹管理中的一个越来越大的挑战.
- 生物疗法提供了一个有希望的策略,以减轻传染性腹的负担.
结论:
- 合作,多学科的方法对于最佳的传染性腹护理是必不可少的.
- 对流行病学,诊断和治疗的最新知识对于有效的管理至关重要.
- 解决抗菌素耐药性和探索生物治疗是未来的关键方向.
更多相关视频
04:56Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
Published on: February 9, 2024
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
相关概念视频
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
